ID   FOXO_CAEEL              Reviewed;         541 AA.
AC   O16850; F3NWW7; F3NWX0; G4RQR7; G4S686; G4SKG3; G4SKH0; O16849; O18676;
AC   Q86S42;
DT   16-JUN-2009, integrated into UniProtKB/Swiss-Prot.
DT   25-JAN-2012, sequence version 3.
DT   18-JUN-2025, entry version 193.
DE   RecName: Full=Forkhead box protein O {ECO:0000305};
DE            Short=FOXO {ECO:0000303|PubMed:12750521};
DE   AltName: Full=Abnormal dauer formation protein 16 {ECO:0000312|WormBase:R13H8.1h};
GN   Name=daf-16 {ECO:0000312|WormBase:R13H8.1h};
GN   ORFNames=R13H8.1 {ECO:0000312|WormBase:R13H8.1h};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAB84390.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=Bristol N2 {ECO:0000312|EMBL:AAB84392.1};
RX   PubMed=9353126; DOI=10.1038/40194;
RA   Ogg S., Paradis S., Gottlieb S., Patterson G.I., Lee L., Tissenbaum H.A.,
RA   Ruvkun G.;
RT   "The Fork head transcription factor DAF-16 transduces insulin-like
RT   metabolic and longevity signals in C. elegans.";
RL   Nature 389:994-999(1997).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C), FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=Bristol N2;
RX   PubMed=9360933; DOI=10.1126/science.278.5341.1319;
RA   Lin K., Dorman J.B., Rodan A., Kenyon C.;
RT   "daf-16: An HNF-3/forkhead family member that can function to double the
RT   life-span of Caenorhabditis elegans.";
RL   Science 278:1319-1322(1997).
RN   [3] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [4]
RP   FUNCTION.
RX   PubMed=8247153; DOI=10.1038/366461a0;
RA   Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R.;
RT   "A C. elegans mutant that lives twice as long as wild type.";
RL   Nature 366:461-464(1993).
RN   [5] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=10880363; DOI=10.1042/0264-6021:3490629;
RA   Furuyama T., Nakazawa T., Nakano I., Mori N.;
RT   "Identification of the differential distribution patterns of mRNAs and
RT   consensus binding sequences for mouse DAF-16 homologues.";
RL   Biochem. J. 349:629-634(2000).
RN   [6] {ECO:0000305}
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11747821; DOI=10.1016/s0960-9822(01)00595-4;
RA   Lee R.Y., Hench J., Ruvkun G.;
RT   "Regulation of C. elegans DAF-16 and its human ortholog FKHRL1 by the daf-2
RT   insulin-like signaling pathway.";
RL   Curr. Biol. 11:1950-1957(2001).
RN   [7] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11747825; DOI=10.1016/s0960-9822(01)00594-2;
RA   Henderson S.T., Johnson T.E.;
RT   "daf-16 integrates developmental and environmental inputs to mediate aging
RT   in the nematode Caenorhabditis elegans.";
RL   Curr. Biol. 11:1975-1980(2001).
RN   [8] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF SER-271; THR-273 AND
RP   SER-345.
RX   PubMed=11381260; DOI=10.1038/88850;
RA   Lin K., Hsin H., Libina N., Kenyon C.;
RT   "Regulation of the Caenorhabditis elegans longevity protein DAF-16 by
RT   insulin/IGF-1 and germline signaling.";
RL   Nat. Genet. 28:139-145(2001).
RN   [9]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=14622602; DOI=10.1016/s0092-8674(03)00889-4;
RA   Libina N., Berman J.R., Kenyon C.;
RT   "Tissue-specific activities of C. elegans DAF-16 in the regulation of
RT   lifespan.";
RL   Cell 115:489-502(2003).
RN   [10] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=12750521; DOI=10.1126/science.1083701;
RA   Hsu A.L., Murphy C.T., Kenyon C.;
RT   "Regulation of aging and age-related disease by DAF-16 and heat-shock
RT   factor.";
RL   Science 300:1142-1145(2003).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15888317; DOI=10.1016/j.mad.2004.11.012;
RA   Kondo M., Yanase S., Ishii T., Hartman P.S., Matsumoto K., Ishii N.;
RT   "The p38 signal transduction pathway participates in the oxidative stress-
RT   mediated translocation of DAF-16 to Caenorhabditis elegans nuclei.";
RL   Mech. Ageing Dev. 126:642-647(2005).
RN   [12]
RP   INTERACTION WITH JNK-1, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=15767565; DOI=10.1073/pnas.0500749102;
RA   Oh S.W., Mukhopadhyay A., Svrzikapa N., Jiang F., Davis R.J.,
RA   Tissenbaum H.A.;
RT   "JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear
RT   translocation of forkhead transcription factor/DAF-16.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:4494-4499(2005).
RN   [13]
RP   INTERACTION WITH FTT-2.
RX   PubMed=16777605; DOI=10.1016/j.cell.2006.04.036;
RA   Berdichevsky A., Viswanathan M., Horvitz H.R., Guarente L.;
RT   "C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and
RT   extend life span.";
RL   Cell 125:1165-1177(2006).
RN   [14]
RP   FUNCTION.
RX   PubMed=17096597; DOI=10.1371/journal.pgen.0020183;
RA   Troemel E.R., Chu S.W., Reinke V., Lee S.S., Ausubel F.M., Kim D.H.;
RT   "p38 MAPK regulates expression of immune response genes and contributes to
RT   longevity in C. elegans.";
RL   PLoS Genet. 2:E183-E183(2006).
RN   [15]
RP   FUNCTION.
RX   PubMed=16902091; DOI=10.1126/science.1124646;
RA   Cohen E., Bieschke J., Perciavalle R.M., Kelly J.W., Dillin A.;
RT   "Opposing activities protect against age-onset proteotoxicity.";
RL   Science 313:1604-1610(2006).
RN   [16]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17551714; DOI=10.1007/s00204-007-0215-4;
RA   Kampkotter A., Gombitang Nkwonkam C., Zurawski R.F., Timpel C.,
RA   Chovolou Y., Watjen W., Kahl R.;
RT   "Effects of the flavonoids kaempferol and fisetin on thermotolerance,
RT   oxidative stress and FoxO transcription factor DAF-16 in the model organism
RT   Caenorhabditis elegans.";
RL   Arch. Toxicol. 81:849-858(2007).
RN   [17]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17900900; DOI=10.1016/j.cub.2007.08.047;
RA   Greer E.L., Dowlatshahi D., Banko M.R., Villen J., Hoang K., Blanchard D.,
RA   Gygi S.P., Brunet A.;
RT   "An AMPK-FOXO pathway mediates longevity induced by a novel method of
RT   dietary restriction in C. elegans.";
RL   Curr. Biol. 17:1646-1656(2007).
RN   [18]
RP   INTERACTION WITH RLE-1, AND UBIQUITINATION.
RX   PubMed=17276341; DOI=10.1016/j.devcel.2006.12.002;
RA   Li W., Gao B., Lee S.-M., Bennett K., Fang D.;
RT   "RLE-1, an E3 ubiquitin ligase, regulates C. elegans aging by catalyzing
RT   DAF-16 polyubiquitination.";
RL   Dev. Cell 12:235-246(2007).
RN   [19]
RP   FUNCTION.
RX   PubMed=17934462; DOI=10.1038/ng.2007.1;
RA   Pinkston-Gosse J., Kenyon C.;
RT   "DAF-16/FOXO targets genes that regulate tumor growth in Caenorhabditis
RT   elegans.";
RL   Nat. Genet. 39:1403-1409(2007).
RN   [20]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18025456; DOI=10.1073/pnas.0709613104;
RA   Murphy C.T., Lee S.J., Kenyon C.;
RT   "Tissue entrainment by feedback regulation of insulin gene expression in
RT   the endoderm of Caenorhabditis elegans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:19046-19050(2007).
RN   [21]
RP   FUNCTION, AND PHOSPHORYLATION BY AKT-1; AKT-2 AND SGK-1.
RX   PubMed=18358814; DOI=10.1016/j.cell.2008.01.030;
RA   Tullet J.M., Hertweck M., An J.H., Baker J., Hwang J.Y., Liu S.,
RA   Oliveira R.P., Baumeister R., Blackwell T.K.;
RT   "Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like
RT   signaling in C. elegans.";
RL   Cell 132:1025-1038(2008).
RN   [22]
RP   FUNCTION.
RX   PubMed=18762027; DOI=10.1016/j.cmet.2008.08.007;
RA   Perez C.L., Van Gilst M.R.;
RT   "A 13C isotope labeling strategy reveals the influence of insulin signaling
RT   on lipogenesis in C. elegans.";
RL   Cell Metab. 8:266-274(2008).
RN   [23]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18832074; DOI=10.1101/gad.478408;
RA   Neumann-Haefelin E., Qi W., Finkbeiner E., Walz G., Baumeister R.,
RA   Hertweck M.;
RT   "SHC-1/p52Shc targets the insulin/IGF-1 and JNK signaling pathways to
RT   modulate life span and stress response in C. elegans.";
RL   Genes Dev. 22:2721-2735(2008).
RN   [24]
RP   FUNCTION.
RX   PubMed=18245330; DOI=10.1534/genetics.107.083923;
RA   Miyata S., Begun J., Troemel E.R., Ausubel F.M.;
RT   "DAF-16-dependent suppression of immunity during reproduction in
RT   Caenorhabditis elegans.";
RL   Genetics 178:903-918(2008).
RN   [25]
RP   FUNCTION.
RX   PubMed=18397876; DOI=10.1093/hmg/ddn109;
RA   Catoire H., Pasco M.Y., Abu-Baker A., Holbert S., Tourette C., Brais B.,
RA   Rouleau G.A., Parker J.A., Neri C.;
RT   "Sirtuin inhibition protects from the polyalanine muscular dystrophy
RT   protein PABPN1.";
RL   Hum. Mol. Genet. 17:2108-2117(2008).
RN   [26]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17894411; DOI=10.1002/jcp.21269;
RA   Wolf M., Nunes F., Henkel A., Heinick A., Paul R.J.;
RT   "The MAP kinase JNK-1 of Caenorhabditis elegans: location, activation, and
RT   influences over temperature-dependent insulin-like signaling, stress
RT   responses, and fitness.";
RL   J. Cell. Physiol. 214:721-729(2008).
RN   [27] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH HCF-1.
RX   PubMed=18828672; DOI=10.1371/journal.pbio.0060233;
RA   Li J., Ebata A., Dong Y., Rizki G., Iwata T., Lee S.S.;
RT   "Caenorhabditis elegans HCF-1 functions in longevity maintenance as a DAF-
RT   16 regulator.";
RL   PLoS Biol. 6:e233-e233(2008).
RN   [28]
RP   FUNCTION.
RX   PubMed=18524954; DOI=10.1073/pnas.0707607105;
RA   Bretscher A.J., Busch K.E., de Bono M.;
RT   "A carbon dioxide avoidance behavior is integrated with responses to
RT   ambient oxygen and food in Caenorhabditis elegans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:8044-8049(2008).
RN   [29]
RP   FUNCTION.
RX   PubMed=19489741; DOI=10.1111/j.1474-9726.2009.00495.x;
RA   Hahm J.H., Kim S., Paik Y.K.;
RT   "Endogenous cGMP regulates adult longevity via the insulin signaling
RT   pathway in Caenorhabditis elegans.";
RL   Aging Cell 8:473-483(2009).
RN   [30]
RP   FUNCTION.
RX   PubMed=19103192; DOI=10.1016/j.ydbio.2008.11.019;
RA   Liachko N., Davidowitz R., Lee S.S.;
RT   "Combined informatic and expression screen identifies the novel DAF-16
RT   target HLH-13.";
RL   Dev. Biol. 327:97-105(2009).
RN   [31]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19252938; DOI=10.1007/s12263-009-0113-x;
RA   Hartwig K., Heidler T., Moch J., Daniel H., Wenzel U.;
RT   "Feeding a ROS-generator to Caenorhabditis elegans leads to increased
RT   expression of small heat shock protein HSP-16.2 and hormesis.";
RL   Genes Nutr. 4:59-67(2009).
RN   [32]
RP   FUNCTION, INTERACTION WITH FTT-2 AND PRMT-1, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION BY AKT, PHOSPHORYLATION AT THR-273, AND MUTAGENESIS OF
RP   ARG-266; ARG-268; ARG-270; SER-271 AND THR-273.
RX   PubMed=21531333; DOI=10.1016/j.cmet.2011.03.017;
RA   Takahashi Y., Daitoku H., Hirota K., Tamiya H., Yokoyama A., Kako K.,
RA   Nagashima Y., Nakamura A., Shimada T., Watanabe S., Yamagata K., Yasuda K.,
RA   Ishii N., Fukamizu A.;
RT   "Asymmetric arginine dimethylation determines life span in C. elegans by
RT   regulating forkhead transcription factor DAF-16.";
RL   Cell Metab. 13:505-516(2011).
RN   [33]
RP   FUNCTION.
RX   PubMed=22081913; DOI=10.1111/j.1474-9726.2011.00768.x;
RA   McCormick M., Chen K., Ramaswamy P., Kenyon C.;
RT   "New genes that extend Caenorhabditis elegans' lifespan in response to
RT   reproductive signals.";
RL   Aging Cell 11:192-202(2012).
RN   [34]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22875284; DOI=10.1007/s00128-012-0760-2;
RA   Wang Y., Jian F., Wu J., Wang S.;
RT   "Stress-response protein expression and DAF-16 translocation were induced
RT   in tributyltin-exposed Caenorhabditis elegans.";
RL   Bull. Environ. Contam. Toxicol. 89:704-711(2012).
RN   [35]
RP   SUBCELLULAR LOCATION.
RX   PubMed=23000058; DOI=10.1016/j.freeradbiomed.2012.08.594;
RA   Shukla V., Yadav D., Phulara S.C., Gupta M.M., Saikia S.K., Pandey R.;
RT   "Longevity-promoting effects of 4-hydroxy-E-globularinin in Caenorhabditis
RT   elegans.";
RL   Free Radic. Biol. Med. 53:1848-1856(2012).
RN   [36]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22922647; DOI=10.1038/nature11315;
RA   Vilchez D., Morantte I., Liu Z., Douglas P.M., Merkwirth C.,
RA   Rodrigues A.P., Manning G., Dillin A.;
RT   "RPN-6 determines C. elegans longevity under proteotoxic stress
RT   conditions.";
RL   Nature 489:263-268(2012).
RN   [37]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22916022; DOI=10.1371/journal.pgen.1002836;
RA   Qi W., Huang X., Neumann-Haefelin E., Schulze E., Baumeister R.;
RT   "Cell-nonautonomous signaling of FOXO/DAF-16 to the stem cells of
RT   Caenorhabditis elegans.";
RL   PLoS Genet. 8:e1002836-e1002836(2012).
RN   [38]
RP   INDUCTION BY QUINIC ACID.
RX   PubMed=22950425; DOI=10.1089/rej.2012.1342;
RA   Zhang L., Zhang J., Zhao B., Zhao-Wilson X.;
RT   "Quinic acid could be a potential rejuvenating natural compound by
RT   improving survival of Caenorhabditis elegans under deleterious
RT   conditions.";
RL   Rejuvenation Res. 15:573-583(2012).
RN   [39]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23770237; DOI=10.1016/j.celrep.2013.05.012;
RA   Matilainen O., Arpalahti L., Rantanen V., Hautaniemi S., Holmberg C.I.;
RT   "Insulin/IGF-1 signaling regulates proteasome activity through the
RT   deubiquitinating enzyme UBH-4.";
RL   Cell Rep. 3:1980-1995(2013).
RN   [40]
RP   INTERACTION WITH UNC-43 AND TAX-6, SUBCELLULAR LOCATION, PHOSPHORYLATION AT
RP   SER-319, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF SER-319.
RX   PubMed=23805378; DOI=10.7554/elife.00518;
RA   Tao L., Xie Q., Ding Y.H., Li S.T., Peng S., Zhang Y.P., Tan D., Yuan Z.,
RA   Dong M.Q.;
RT   "CAMKII and Calcineurin regulate the lifespan of Caenorhabditis elegans
RT   through the FOXO transcription factor DAF-16.";
RL   Elife 2:E00518-E00518(2013).
RN   [41]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=24146615; DOI=10.1371/journal.ppat.1003660;
RA   Zou C.G., Tu Q., Niu J., Ji X.L., Zhang K.Q.;
RT   "The DAF-16/FOXO transcription factor functions as a regulator of epidermal
RT   innate immunity.";
RL   PLoS Pathog. 9:E1003660-E1003660(2013).
RN   [42]
RP   FUNCTION.
RX   PubMed=25448701; DOI=10.1016/j.cmet.2014.09.006;
RA   Safra M., Fickentscher R., Levi-Ferber M., Danino Y.M., Haviv-Chesner A.,
RA   Hansen M., Juven-Gershon T., Weiss M., Henis-Korenblit S.;
RT   "The FOXO transcription factor DAF-16 bypasses ire-1 requirement to promote
RT   endoplasmic reticulum hoymeostasis.";
RL   Cell Metab. 20:870-881(2014).
RN   [43]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=24957743; DOI=10.1007/s12263-014-0414-6;
RA   Fischer M., Fitzenberger E., Kull R., Boll M., Wenzel U.;
RT   "The zinc matrix metalloproteinase ZMP-2 increases survival of
RT   Caenorhabditis elegans through interference with lipoprotein absorption.";
RL   Genes Nutr. 9:414-414(2014).
RN   [44]
RP   FUNCTION (ISOFORMS A; D AND F), AND DEVELOPMENTAL STAGE (ISOFORMS A; D AND
RP   F).
RX   PubMed=24834345; DOI=10.1186/2046-2395-3-5;
RA   Bansal A., Kwon E.S., Conte D. Jr., Liu H., Gilchrist M.J., MacNeil L.T.,
RA   Tissenbaum H.A.;
RT   "Transcriptional regulation of Caenorhabditis elegans FOXO/DAF-16 modulates
RT   lifespan.";
RL   Longev. Healthspan 3:5-5(2014).
RN   [45]
RP   FUNCTION.
RX   PubMed=25383666; DOI=10.1038/nsmb.2915;
RA   Nakagawa A., Sullivan K.D., Xue D.;
RT   "Caspase-activated phosphoinositide binding by CNT-1 promotes apoptosis by
RT   inhibiting the AKT pathway.";
RL   Nat. Struct. Mol. Biol. 21:1082-1090(2014).
RN   [46]
RP   FUNCTION.
RX   PubMed=24516399; DOI=10.1371/journal.pgen.1004109;
RA   Tullet J.M., Araiz C., Sanders M.J., Au C., Benedetto A., Papatheodorou I.,
RA   Clark E., Schmeisser K., Jones D., Schuster E.F., Thornton J.M., Gems D.;
RT   "DAF-16/FoxO directly regulates an atypical AMP-activated protein kinase
RT   gamma isoform to mediate the effects of insulin/IGF-1 signaling on aging in
RT   Caenorhabditis elegans.";
RL   PLoS Genet. 10:E1004109-E1004109(2014).
RN   [47]
RP   FUNCTION.
RX   PubMed=25330323; DOI=10.1371/journal.pgen.1004703;
RA   Warnhoff K., Murphy J.T., Kumar S., Schneider D.L., Peterson M., Hsu S.,
RA   Guthrie J., Robertson J.D., Kornfeld K.;
RT   "The DAF-16 FOXO transcription factor regulates natc-1 to modulate stress
RT   resistance in Caenorhabditis elegans, linking insulin/IGF-1 signaling to
RT   protein N-terminal acetylation.";
RL   PLoS Genet. 10:E1004703-E1004703(2014).
RN   [48]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=25357003; DOI=10.1371/journal.pgen.1004707;
RA   Gruner M., Nelson D., Winbush A., Hintz R., Ryu L., Chung S.H., Kim K.,
RA   Gabel C.V., van der Linden A.M.;
RT   "Feeding state, insulin and NPR-1 modulate Chemoreceptor gene expression
RT   via integration of sensory and circuit inputs.";
RL   PLoS Genet. 10:E1004707-E1004707(2014).
RN   [49] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=26675724; DOI=10.1038/nature16483;
RA   Kaletsky R., Lakhina V., Arey R., Williams A., Landis J., Ashraf J.,
RA   Murphy C.T.;
RT   "The C. elegans adult neuronal IIS/FOXO transcriptome reveals adult
RT   phenotype regulators.";
RL   Nature 529:92-96(2016).
RN   [50]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=28285998; DOI=10.1016/j.cub.2017.02.015;
RA   Ames K., Da Cunha D.S., Gonzalez B., Konta M., Lin F., Shechter G.,
RA   Starikov L., Wong S., Buelow H.E., Melendez A.;
RT   "A Non-Cell-Autonomous Role of BEC-1/BECN1/Beclin1 in Coordinating Cell-
RT   Cycle Progression and Stem Cell Proliferation during Germline
RT   Development.";
RL   Curr. Biol. 27:905-913(2017).
RN   [51]
RP   FUNCTION.
RX   PubMed=29523076; DOI=10.1186/s12868-018-0408-1;
RA   Bennett H.L., Khoruzhik Y., Hayden D., Huang H., Sanders J., Walsh M.B.,
RA   Biron D., Hart A.C.;
RT   "Normal sleep bouts are not essential for C. elegans survival and FoxO is
RT   important for compensatory changes in sleep.";
RL   BMC Neurosci. 19:10-10(2018).
RN   [52]
RP   FUNCTION.
RX   PubMed=29500338; DOI=10.1038/s41467-018-02934-5;
RA   De Magalhaes Filho C.D., Henriquez B., Seah N.E., Evans R.M.,
RA   Lapierre L.R., Dillin A.;
RT   "Visible light reduces C. elegans longevity.";
RL   Nat. Commun. 9:927-927(2018).
RN   [53]
RP   FUNCTION, AND MUTAGENESIS OF 373-TRP--LEU-541.
RX   PubMed=30409788; DOI=10.1534/genetics.118.301557;
RA   Flatt K.M., Beshers C., Unal C., Cohen J.D., Sundaram M.V., Schroeder N.E.;
RT   "Epidermal Remodeling in Caenorhabditis elegans Dauers Requires the Nidogen
RT   Domain Protein DEX-1.";
RL   Genetics 211:169-183(2019).
RN   [54]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=30779740; DOI=10.1371/journal.pgen.1007945;
RA   Peymen K., Watteyne J., Borghgraef C., Van Sinay E., Beets I., Schoofs L.;
RT   "Myoinhibitory peptide signaling modulates aversive gustatory learning in
RT   Caenorhabditis elegans.";
RL   PLoS Genet. 15:E1007945-E1007945(2019).
RN   [55] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=30613772; DOI=10.1126/sciadv.aau5041;
RA   Li G., Gong J., Liu J., Liu J., Li H., Hsu A.L., Liu J., Xu X.Z.S.;
RT   "Genetic and pharmacological interventions in the aging motor nervous
RT   system slow motor impairment and extend life span in C. elegans.";
RL   Sci. Adv. 5:eaau5041-eaau5041(2019).
RN   [56]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=35140229; DOI=10.1038/s41467-022-28469-4;
RA   Wan Q.L., Meng X., Wang C., Dai W., Luo Z., Yin Z., Ju Z., Fu X., Yang J.,
RA   Ye Q., Zhang Z.H., Zhou Q.;
RT   "Histone H3K4me3 modification is a transgenerational epigenetic signal for
RT   lipid metabolism in Caenorhabditis elegans.";
RL   Nat. Commun. 13:768-768(2022).
CC   -!- FUNCTION: Forkhead-type transcription factor (PubMed:9360933). Binds to
CC       the promoters of genes that contain the daf-16/FOXO binding element
CC       (DBE), TTGTTTAC, in their regulatory region (PubMed:10880363,
CC       PubMed:23770237, PubMed:26675724). Functions in the Insulin/IGF-1-like
CC       signaling (IIS) mediated pathway which affects lipogenesis, lifespan,
CC       starvation survival, heat shock and oxidative stress responses, sleep,
CC       associative memory, and dauer formation (PubMed:11381260,
CC       PubMed:11747821, PubMed:11747825, PubMed:12750521, PubMed:14622602,
CC       PubMed:17900900, PubMed:18358814, PubMed:18762027, PubMed:18832074,
CC       PubMed:19103192, PubMed:21531333, PubMed:22081913, PubMed:26675724,
CC       PubMed:29523076, PubMed:8247153, PubMed:9360933). Longevity signaling
CC       predominantly arises from expression in the intestine
CC       (PubMed:14622602). Acts in the intestine to mediate the role of slo-1
CC       in age-associated decline in motor activity and longevity
CC       (PubMed:30613772). Transcriptional activity of daf-16/FOXO is
CC       negatively regulated by interaction with host cell factor homolog hcf-
CC       1; and by cytoplasmic sequestration by association with ftt-2
CC       (PubMed:11381260, PubMed:18828672, PubMed:21531333). Inhibition is
CC       required for the carbon dioxide (CO2) avoidance response
CC       (PubMed:18524954). Upon loss of inhibition, daf-16 translocates to the
CC       nucleus to regulate genes that result in delayed reproduction and
CC       growth while increasing stress resistance starvation tolerance and
CC       longevity (PubMed:11747825, PubMed:21531333). Association with arginine
CC       methyltransferase prmt-1 prevents phosphorylation and allows for
CC       translocation to the nucleus and the subsequent transcription of
CC       longevity-related genes (PubMed:21531333). Modulation of its activity
CC       by cGMP levels in sensory neurons regulates lifespan (PubMed:19489741).
CC       Has a protective role against muscle dystrophy (PubMed:18397876).
CC       Involved in mediating protection against aberrant protein aggregation
CC       proteotoxicity (PubMed:16902091). Influences transcription of genes
CC       that code for proteins involved in immunity as part of a general stress
CC       response (PubMed:17096597, PubMed:18245330). Targets genes that inhibit
CC       and stimulate tumor growth (PubMed:17934462). Targets kinases,
CC       phosphatases and transcription factors that are primarily involved in
CC       signaling and gene regulation (PubMed:24516399). Thought to regulate
CC       ins-7 in FOXO-to-FOXO signaling, which coordinates daf-16 expression
CC       (PubMed:18025456). Activity is positively regulated by shc-1-mediated
CC       inhibition of daf-2 and activation of JNK pathway (PubMed:18832074,
CC       PubMed:22916022). Through the regulation of its activity by shc-1-
CC       mediated inhibition of daf-2 and activation of JNK pathway, plays a
CC       role in maintaining the integrity of the gonad (PubMed:22916022).
CC       Functions by indirect interaction with jnk-1 of the mitogen-activated
CC       protein kinase (MAPK) pathway (PubMed:17894411). Involved in increased
CC       proteasome activity by activating expression of rpn-6.1 in response to
CC       proteotoxic stress, leading to enhanced assembly of the 26S proteasome,
CC       followed by higher proteasome activity (PubMed:22922647). Also
CC       regulates proteasome activity in the intestine by preventing expression
CC       of deubiquitinase ubh-4 (PubMed:23770237). Represses transcription of
CC       natc-1 (PubMed:25330323). Involved in regulation of srh-234 expression
CC       (PubMed:25357003). Binds to the promoter of the AMPK-gamma regulatory
CC       subunit, aakg-4, and activates its transcription (PubMed:24516399).
CC       Also activates transcription of AMPK-gamma regulatory subunit, aakg-1
CC       (PubMed:24516399). Maintains endoplasmic reticulum (ER) function by
CC       inducing protein degradation and elimination to remove misfolded
CC       secretory proteins from the ER independently of the ire-1/xbp-1
CC       unfolded protein response pathway (PubMed:25448701). Regulates
CC       epidermal innate immunity to nematophagous fungal infection and
CC       physical wounding which trigger bli-3 induced ROS release, leading to
CC       daf-16 activation independently of daf-2 signaling (PubMed:24146615).
CC       May negatively regulate resistance to stress caused by oxidized
CC       cholesterol adducts by preventing the activation of daf-9 and nuclear
CC       hormone receptor daf-12, two members of the steroid signaling pathway
CC       (PubMed:24957743). Promotes apoptosis during embryonic development
CC       (PubMed:25383666). Probably through the regulation of the autophagy
CC       genes atg-18 and atg-16.2, plays a role in regulating stem cell number
CC       in the germline during larval development (PubMed:28285998). Plays a
CC       role in learning and memory; including associative memory, and aversive
CC       gustatory associated learning known as salt avoidance learning
CC       (PubMed:26675724, PubMed:30779740). Plays a role in regulating gene
CC       transcription in response to white light exposure (PubMed:29500338).
CC       Binds to the promoter of dex-1 to positively regulate its expression in
CC       seam cells during the dauer phase (PubMed:30409788). Plays a role in
CC       transgenerational lipid accumulation in response to a high-fat diet
CC       (PubMed:35140229). {ECO:0000269|PubMed:10880363,
CC       ECO:0000269|PubMed:11381260, ECO:0000269|PubMed:11747821,
CC       ECO:0000269|PubMed:11747825, ECO:0000269|PubMed:12750521,
CC       ECO:0000269|PubMed:14622602, ECO:0000269|PubMed:16902091,
CC       ECO:0000269|PubMed:17096597, ECO:0000269|PubMed:17894411,
CC       ECO:0000269|PubMed:17900900, ECO:0000269|PubMed:17934462,
CC       ECO:0000269|PubMed:18025456, ECO:0000269|PubMed:18245330,
CC       ECO:0000269|PubMed:18358814, ECO:0000269|PubMed:18397876,
CC       ECO:0000269|PubMed:18524954, ECO:0000269|PubMed:18762027,
CC       ECO:0000269|PubMed:18832074, ECO:0000269|PubMed:19103192,
CC       ECO:0000269|PubMed:19489741, ECO:0000269|PubMed:21531333,
CC       ECO:0000269|PubMed:22081913, ECO:0000269|PubMed:22916022,
CC       ECO:0000269|PubMed:22922647, ECO:0000269|PubMed:23770237,
CC       ECO:0000269|PubMed:24146615, ECO:0000269|PubMed:24516399,
CC       ECO:0000269|PubMed:24957743, ECO:0000269|PubMed:25330323,
CC       ECO:0000269|PubMed:25357003, ECO:0000269|PubMed:25383666,
CC       ECO:0000269|PubMed:25448701, ECO:0000269|PubMed:28285998,
CC       ECO:0000269|PubMed:29500338, ECO:0000269|PubMed:30409788,
CC       ECO:0000269|PubMed:30613772, ECO:0000269|PubMed:30779740,
CC       ECO:0000269|PubMed:8247153, ECO:0000269|PubMed:9360933}.
CC   -!- FUNCTION: [Isoform a]: Functions in the Insulin/IGF-1-like signaling
CC       (IIS) mediated pathway (PubMed:24834345). May play a role in lifespan
CC       modulation, but less significant than that played by isoforms d and f
CC       (PubMed:24834345). {ECO:0000269|PubMed:24834345}.
CC   -!- FUNCTION: [Isoform d]: Functions in the Insulin/IGF-1-like signaling
CC       (IIS) mediated pathway (PubMed:24834345). Transcript level in the early
CC       adult may play a role in lifespan modulation, but effect is more
CC       significant than that played by isoform a (PubMed:24834345).
CC       {ECO:0000269|PubMed:24834345}.
CC   -!- FUNCTION: [Isoform f]: Functions in the Insulin/IGF-1-like signaling
CC       (IIS) mediated pathway (PubMed:24834345). Transcript level in the early
CC       adult may play a role in lifespan modulation, but effect is more
CC       significant than that played by isoform a (PubMed:24834345).
CC       {ECO:0000269|PubMed:24834345}.
CC   -!- SUBUNIT: Interacts with rle-1 (PubMed:17276341). Interacts with unc-43
CC       and tax-6 (PubMed:23805378). Interacts with jnk-1 (PubMed:15767565).
CC       Interacts with ftt-2 (PubMed:16777605, PubMed:21531333). Interacts with
CC       prmt-1 (PubMed:21531333). Interacts with hcf-1.
CC       {ECO:0000269|PubMed:15767565, ECO:0000269|PubMed:17276341,
CC       ECO:0000269|PubMed:18828672, ECO:0000269|PubMed:21531333,
CC       ECO:0000269|PubMed:23805378}.
CC   -!- INTERACTION:
CC       O16850; Q17941: akt-1; NbExp=3; IntAct=EBI-324028, EBI-1770718;
CC       O16850; Q9XTG7: akt-2; NbExp=3; IntAct=EBI-324028, EBI-320656;
CC       O16850; Q2PJ68: sgk-1; NbExp=3; IntAct=EBI-324028, EBI-1770776;
CC       O16850; Q21921: sir-2.1; NbExp=2; IntAct=EBI-324028, EBI-966082;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11381260,
CC       ECO:0000269|PubMed:11747825, ECO:0000269|PubMed:15767565,
CC       ECO:0000269|PubMed:15888317, ECO:0000269|PubMed:17551714,
CC       ECO:0000269|PubMed:17894411, ECO:0000269|PubMed:18832074,
CC       ECO:0000269|PubMed:19252938, ECO:0000269|PubMed:21531333,
CC       ECO:0000269|PubMed:22916022, ECO:0000269|PubMed:23805378,
CC       ECO:0000269|PubMed:24146615}. Cytoplasm {ECO:0000269|PubMed:11381260,
CC       ECO:0000269|PubMed:11747825, ECO:0000269|PubMed:15767565,
CC       ECO:0000269|PubMed:15888317, ECO:0000269|PubMed:17551714,
CC       ECO:0000269|PubMed:17894411, ECO:0000269|PubMed:18832074,
CC       ECO:0000269|PubMed:19252938, ECO:0000269|PubMed:21531333,
CC       ECO:0000269|PubMed:22916022, ECO:0000269|PubMed:23805378,
CC       ECO:0000269|PubMed:24146615}. Note=Shuttles between cytoplasm and
CC       nucleus (PubMed:11381260, PubMed:17894411). Nuclear translocation is
CC       inhibited by phosphorylation by AKT proteins (PubMed:11381260,
CC       PubMed:11747825, PubMed:21531333). Association with ftt-2 sequesters
CC       daf-16 in the cytoplasm (PubMed:21531333). Association with prmt-1
CC       allows for translocation to the nucleus (PubMed:21531333). Nuclear
CC       translocation is promoted by phosphorylation by unc-43 and inhibited by
CC       dephosphorylation by tax-6 (PubMed:23805378). Nuclear translocation is
CC       promoted by jnk-1 upon heat stress and by sek-1 upon oxidative stress
CC       (PubMed:15767565, PubMed:15888317). Nucleocytoplasmic shuttling is
CC       induced by starvation, heat treatment, hypergravity, reactive oxygen
CC       species (generated by juglone), exposure to tributyltin or 4-hydroxy-E-
CC       globularinin (4-HEG) and the flavonoids kaempferol and fisetin
CC       (PubMed:11381260, PubMed:17551714, PubMed:18832074, PubMed:19252938,
CC       PubMed:21531333, PubMed:23805378). Nuclear localization induced by
CC       nematophagous fungal infection (PubMed:24146615).
CC       {ECO:0000269|PubMed:11381260, ECO:0000269|PubMed:11747825,
CC       ECO:0000269|PubMed:15767565, ECO:0000269|PubMed:15888317,
CC       ECO:0000269|PubMed:17551714, ECO:0000269|PubMed:17894411,
CC       ECO:0000269|PubMed:18832074, ECO:0000269|PubMed:19252938,
CC       ECO:0000269|PubMed:21531333, ECO:0000269|PubMed:24146615}.
CC   -!- SUBCELLULAR LOCATION: [Isoform a]: Nucleus
CC       {ECO:0000269|PubMed:24834345}. Cytoplasm {ECO:0000269|PubMed:24834345}.
CC       Note=Ratio of nuclear to cytoplasmic localization is daf-2-dependent.
CC       {ECO:0000269|PubMed:24834345}.
CC   -!- SUBCELLULAR LOCATION: [Isoform d]: Nucleus
CC       {ECO:0000269|PubMed:24834345}. Cytoplasm {ECO:0000269|PubMed:24834345}.
CC       Note=Ratio of nuclear to cytoplasmic localization is daf-2-dependent.
CC       {ECO:0000269|PubMed:24834345}.
CC   -!- SUBCELLULAR LOCATION: [Isoform f]: Nucleus
CC       {ECO:0000269|PubMed:24834345}. Cytoplasm {ECO:0000269|PubMed:24834345}.
CC       Note=Ratio of nuclear to cytoplasmic localization is daf-2-dependent.
CC       {ECO:0000269|PubMed:24834345}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=h {ECO:0000312|WormBase:R13H8.1h};
CC         IsoId=O16850-8; Sequence=Displayed;
CC       Name=a {ECO:0000312|WormBase:R13H8.1a}; Synonyms=b
CC       {ECO:0000303|PubMed:9353126};
CC         IsoId=O16850-2; Sequence=VSP_053106;
CC       Name=b {ECO:0000312|WormBase:R13H8.1b}; Synonyms=a2
CC       {ECO:0000303|PubMed:9353126};
CC         IsoId=O16850-4; Sequence=VSP_053107, VSP_053109;
CC       Name=c {ECO:0000312|WormBase:R13H8.1c}; Synonyms=a1
CC       {ECO:0000303|PubMed:9353126};
CC         IsoId=O16850-3; Sequence=VSP_053107;
CC       Name=d {ECO:0000312|WormBase:R13H8.1d};
CC         IsoId=O16850-5; Sequence=VSP_053108;
CC       Name=e {ECO:0000312|WormBase:R13H8.1e};
CC         IsoId=O16850-6; Sequence=VSP_053105;
CC       Name=f {ECO:0000312|WormBase:R13H8.1f};
CC         IsoId=O16850-1; Sequence=VSP_042148;
CC   -!- TISSUE SPECIFICITY: Isoform b and isoform c are expressed in ectoderm,
CC       muscles, intestine and neurons (PubMed:11747825, PubMed:14622602,
CC       PubMed:17894411, PubMed:9353126). Isoform b is also expressed in the
CC       pharynx (PubMed:11747821). The intestine appears to be the primary site
CC       of longevity function (PubMed:14622602). {ECO:0000269|PubMed:11747821,
CC       ECO:0000269|PubMed:11747825, ECO:0000269|PubMed:14622602,
CC       ECO:0000269|PubMed:17894411, ECO:0000269|PubMed:9353126}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryos, larvae, dauer larvae and
CC       adults. {ECO:0000269|PubMed:9353126}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform a]: Expression throughout the body
CC       increases slightly with age. {ECO:0000269|PubMed:24834345}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform d]: Expression increases substantially
CC       with age. {ECO:0000269|PubMed:24834345}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform f]: Expression increases substantially
CC       with age. {ECO:0000269|PubMed:24834345}.
CC   -!- INDUCTION: Induced by quinic acid. {ECO:0000269|PubMed:22950425}.
CC   -!- PTM: Phosphorylated by akt-1 and/or akt-2 (PubMed:18358814,
CC       PubMed:21531333). Phosphorylated by sgk-1 (PubMed:18358814).
CC       Phosphorylated by unc-43 (PubMed:23805378). Phosphorylated by jnk-1
CC       (PubMed:15767565). Dephosphorylated by tax-6 in vitro
CC       (PubMed:23805378). {ECO:0000269|PubMed:15767565,
CC       ECO:0000269|PubMed:18358814, ECO:0000269|PubMed:21531333,
CC       ECO:0000269|PubMed:23805378}.
CC   -!- PTM: Ubiquitinated. Ubiquitination by rle-1 leads to proteasome-
CC       mediated degradation. {ECO:0000269|PubMed:17276341}.
CC   -!- PTM: Methylation by prmt-1 prevents phosphorylation and promotes
CC       translocation to the nucleus to allow for daf-16-dependent
CC       transcription. {ECO:0000269|PubMed:21531333}.
CC   -!- DISRUPTION PHENOTYPE: Dauer defective phenotype in larvae and a reduced
CC       stress phenotype in adults (PubMed:9360933). Increased carbonyl
CC       accumulation and increased sensitivity to starvation (PubMed:18025456).
CC       Increased expression of the srh-234 chemoreceptor during starvation
CC       (PubMed:25357003). Increased sensitivity to physical injury and more
CC       susceptible to death by nematophagous fungal infection
CC       (PubMed:24146615). Reduces life span and motor activity throughout life
CC       (PubMed:23805378, PubMed:30613772). Suppresses the life-span extension
CC       and higher motor activity in aged slo-1 background mutant
CC       (PubMed:30613772). Causes a delay in apoptosis during embryonic
CC       development (PubMed:25383666). Defective gustatory associative learning
CC       in response to salt cues (PubMed:30779740). RNAi-mediated knock-down
CC       reduces expression of daf-16 target genes and genes up-regulated in
CC       response to nematophagous fungal infection such as sod-3
CC       (PubMed:24146615). RNAi-mediated knockdown causes reduced ability of
CC       dietary restriction to extend lifespan (PubMed:17900900). Simultaneous
CC       RNAi-mediated knockdown of metalloproteinase zmp-2 restores normal
CC       survival upon heat stress and prevents increased susceptibility to heat
CC       stress in a daf-9 or daf-12 mutant background (PubMed:24957743). RNAi-
CC       mediated knockdown in a daf-2 (e1370) mutant background restores
CC       expression of deubiquitinase ubh-4 in the intestine (PubMed:23770237).
CC       RNAi-mediated knockdown suppresses the decreased number of mitotic
CC       nuclei in the germline of developing larvae in an atg-18 (gk378) or
CC       atg-16.2 (ok3224) mutant background. Suppresses associative memory,
CC       axon regeneration and fkh-9 transcript levels, in a daf-2 mutant
CC       background. RNAi-mediated knockdown in the first generation offspring
CC       (F1) of adults fed a high-fat diet prevents lipid accumulation
CC       (PubMed:35140229). {ECO:0000269|PubMed:17900900,
CC       ECO:0000269|PubMed:18025456, ECO:0000269|PubMed:23770237,
CC       ECO:0000269|PubMed:23805378, ECO:0000269|PubMed:24146615,
CC       ECO:0000269|PubMed:24957743, ECO:0000269|PubMed:25357003,
CC       ECO:0000269|PubMed:25383666, ECO:0000269|PubMed:26675724,
CC       ECO:0000269|PubMed:30613772, ECO:0000269|PubMed:30779740,
CC       ECO:0000269|PubMed:9360933}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF020342; AAB84390.1; -; mRNA.
DR   EMBL; AF020343; AAB84391.1; -; mRNA.
DR   EMBL; AF020344; AAB84392.1; -; mRNA.
DR   EMBL; AF032112; AAC47803.1; -; mRNA.
DR   EMBL; BX284601; CCD71850.1; -; Genomic_DNA.
DR   EMBL; BX284601; CCD71851.1; -; Genomic_DNA.
DR   EMBL; BX284601; CCD71852.1; -; Genomic_DNA.
DR   EMBL; BX284601; CCD71853.1; -; Genomic_DNA.
DR   EMBL; BX284601; CCD71855.1; -; Genomic_DNA.
DR   EMBL; FO080113; CCD71855.1; JOINED; Genomic_DNA.
DR   EMBL; BX284601; CCD71856.1; -; Genomic_DNA.
DR   EMBL; FO080113; CCD71856.1; JOINED; Genomic_DNA.
DR   EMBL; BX284601; CCD71857.1; -; Genomic_DNA.
DR   EMBL; FO080113; CCD71857.1; JOINED; Genomic_DNA.
DR   PIR; T42234; T42234.
DR   PIR; T42255; T42255.
DR   RefSeq; NP_001021593.1; NM_001026422.6. [O16850-2]
DR   RefSeq; NP_001021594.1; NM_001026423.4.
DR   RefSeq; NP_001021595.1; NM_001026424.4.
DR   RefSeq; NP_001021596.1; NM_001026425.6. [O16850-5]
DR   RefSeq; NP_001021597.1; NM_001026426.2.
DR   RefSeq; NP_001021598.2; NM_001026427.7. [O16850-1]
DR   RefSeq; NP_001251490.1; NM_001264561.1.
DR   RefSeq; NP_001364784.1; NM_001377628.3. [O16850-4]
DR   RefSeq; NP_001364785.1; NM_001377627.2. [O16850-3]
DR   RefSeq; NP_001367892.1; NM_001381210.1. [O16850-6]
DR   RefSeq; NP_001367893.1; NM_001381205.1. [O16850-8]
DR   AlphaFoldDB; O16850; -.
DR   SMR; O16850; -.
DR   BioGRID; 38392; 70.
DR   ComplexPortal; CPX-3882; daf-16-ftt-2 complex.
DR   ComplexPortal; CPX-3883; daf-16-sir-2.1 complex.
DR   ComplexPortal; CPX-3884; daf-16-par-5 complex.
DR   DIP; DIP-25581N; -.
DR   FunCoup; O16850; 320.
DR   IntAct; O16850; 23.
DR   STRING; 6239.R13H8.1h.1; -.
DR   iPTMnet; O16850; -.
DR   PaxDb; 6239-R13H8.1h; -.
DR   PeptideAtlas; O16850; -.
DR   EnsemblMetazoa; R13H8.1a.1; R13H8.1a.1; WBGene00000912. [O16850-2]
DR   EnsemblMetazoa; R13H8.1b.1; R13H8.1b.1; WBGene00000912. [O16850-4]
DR   EnsemblMetazoa; R13H8.1c.1; R13H8.1c.1; WBGene00000912. [O16850-3]
DR   EnsemblMetazoa; R13H8.1d.1; R13H8.1d.1; WBGene00000912. [O16850-5]
DR   EnsemblMetazoa; R13H8.1e.1; R13H8.1e.1; WBGene00000912. [O16850-6]
DR   EnsemblMetazoa; R13H8.1f.1; R13H8.1f.1; WBGene00000912. [O16850-1]
DR   EnsemblMetazoa; R13H8.1h.1; R13H8.1h.1; WBGene00000912. [O16850-8]
DR   GeneID; 172981; -.
DR   KEGG; cel:CELE_R13H8.1; -.
DR   UCSC; R13H8.1c; c. elegans.
DR   AGR; WB:WBGene00000912; -.
DR   CTD; 172981; -.
DR   WormBase; R13H8.1a; CE28771; WBGene00000912; daf-16. [O16850-2]
DR   WormBase; R13H8.1b; CE28772; WBGene00000912; daf-16. [O16850-4]
DR   WormBase; R13H8.1c; CE28773; WBGene00000912; daf-16. [O16850-3]
DR   WormBase; R13H8.1d; CE38722; WBGene00000912; daf-16. [O16850-5]
DR   WormBase; R13H8.1e; CE33160; WBGene00000912; daf-16. [O16850-6]
DR   WormBase; R13H8.1f; CE44821; WBGene00000912; daf-16. [O16850-1]
DR   WormBase; R13H8.1h; CE45185; WBGene00000912; daf-16. [O16850-8]
DR   eggNOG; KOG2294; Eukaryota.
DR   GeneTree; ENSGT00940000170843; -.
DR   InParanoid; O16850; -.
DR   OMA; FSANIAY; -.
DR   OrthoDB; 5954824at2759; -.
DR   PhylomeDB; O16850; -.
DR   Reactome; R-CEL-1181150; Signaling by NODAL.
DR   Reactome; R-CEL-198693; AKT phosphorylates targets in the nucleus.
DR   Reactome; R-CEL-211163; AKT-mediated inactivation of FOXO1A.
DR   Reactome; R-CEL-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-CEL-5689880; Ub-specific processing proteases.
DR   Reactome; R-CEL-9607240; FLT3 Signaling.
DR   Reactome; R-CEL-9614399; Regulation of localization of FOXO transcription factors.
DR   Reactome; R-CEL-9615017; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes.
DR   Reactome; R-CEL-9617629; Regulation of FOXO transcriptional activity by acetylation.
DR   Reactome; R-CEL-9617828; FOXO-mediated transcription of cell cycle genes.
DR   Reactome; R-CEL-9634638; Estrogen-dependent nuclear events downstream of ESR-membrane signaling.
DR   Reactome; R-CEL-9841251; Mitochondrial unfolded protein response (UPRmt).
DR   SignaLink; O16850; -.
DR   PRO; PR:O16850; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00000912; Expressed in larva and 5 other cell types or tissues.
DR   ExpressionAtlas; O16850; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0071889; F:14-3-3 protein binding; IPI:UniProtKB.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0017151; F:DEAD/H-box RNA helicase binding; IPI:WormBase.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:WormBase.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IMP:UniProtKB.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:WormBase.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IPI:WormBase.
DR   GO; GO:0034605; P:cellular response to heat; IDA:UniProtKB.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0040024; P:dauer larval development; IGI:WormBase.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IMP:WormBase.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IMP:UniProtKB.
DR   GO; GO:0008340; P:determination of adult lifespan; IDA:UniProtKB.
DR   GO; GO:0006974; P:DNA damage response; IDA:UniProtKB.
DR   GO; GO:0010286; P:heat acclimation; IGI:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IMP:WormBase.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IDA:WormBase.
DR   GO; GO:0035556; P:intracellular signal transduction; IMP:UniProtKB.
DR   GO; GO:0051457; P:maintenance of protein location in nucleus; NAS:ComplexPortal.
DR   GO; GO:0060537; P:muscle tissue development; IMP:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; NAS:ComplexPortal.
DR   GO; GO:0040015; P:negative regulation of multicellular organism growth; IMP:WormBase.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0002119; P:nematode larval development; IMP:UniProtKB.
DR   GO; GO:0002821; P:positive regulation of adaptive immune response; IMP:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0061066; P:positive regulation of dauer larval development; IMP:WormBase.
DR   GO; GO:1900426; P:positive regulation of defense response to bacterium; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:1900075; P:positive regulation of neuromuscular synaptic transmission; IGI:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0045887; P:positive regulation of synaptic assembly at neuromuscular junction; IGI:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:WormBase.
DR   GO; GO:0010564; P:regulation of cell cycle process; IEP:UniProtKB.
DR   GO; GO:1905909; P:regulation of dauer entry; IGI:UniProtKB.
DR   GO; GO:0061065; P:regulation of dauer larval development; IGI:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0046890; P:regulation of lipid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0010883; P:regulation of lipid storage; IGI:UniProtKB.
DR   GO; GO:0008582; P:regulation of synaptic assembly at neuromuscular junction; IGI:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006979; P:response to oxidative stress; IGI:UniProtKB.
DR   GO; GO:0042594; P:response to starvation; IMP:UniProtKB.
DR   GO; GO:0009411; P:response to UV; IDA:UniProtKB.
DR   GO; GO:0007614; P:short-term memory; IGI:WormBase.
DR   GO; GO:0030431; P:sleep; IGI:UniProtKB.
DR   CDD; cd20032; FH_FOXO; 1.
DR   FunFam; 1.10.10.10:FF:000032; Forkhead box protein O4; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR001766; Fork_head_dom.
DR   InterPro; IPR030456; TF_fork_head_CS_2.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR45767; FORKHEAD BOX PROTEIN O; 1.
DR   PANTHER; PTHR45767:SF2; FORKHEAD BOX PROTEIN O; 1.
DR   Pfam; PF00250; Forkhead; 1.
DR   PRINTS; PR00053; FORKHEAD.
DR   SMART; SM00339; FH; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
DR   PROSITE; PS00658; FORK_HEAD_2; 1.
DR   PROSITE; PS50039; FORK_HEAD_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Developmental protein; DNA-binding;
KW   Growth regulation; Immunity; Innate immunity; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Stress response; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..541
FT                   /note="Forkhead box protein O"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000414886"
FT   DNA_BIND        175..268
FT                   /note="Fork-head"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00089"
FT   REGION          118..168
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          252..291
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        118..150
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         273
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:21531333"
FT   MOD_RES         319
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000269|PubMed:23805378"
FT   VAR_SEQ         1..238
FT                   /note="Missing (in isoform e)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053105"
FT   VAR_SEQ         1..221
FT                   /note="MQLEQKSSLHCSKCRNFLQKFSQDMQAWNCRELDSPLPSDITLHNLEPARPD
FT                   SGMSFSTDFDDDFFNLDLHQQERSASFGGVTQYSQQFLREKCSFSPYFHTSLETVDSGR
FT                   TSLYGSNEQCGQLGGASSNGSTAMLHTPDGSNSHQTSFPSDFRMSESPDDTVSGKKTTT
FT                   RRNAWGNMSYAELITTAIMASPEKRLTLAQVYEWMVQNVPYFRDKGDSNSS -> MNDS
FT                   IDDDFPPEPRGRCYTWPMQQYIYQESSATIPHHHLNQHNNPYHPMHPHHQLPHMQQLPQ
FT                   PLLNLNMTTLTSSGSSVASSIGGGAQCSPCASGSSTAATNSSQQQQTVGQMLAASVPCS
FT                   SSGMTLGMSLNLSQGGGPMPAKKKRCRKKPTDQLAQKKPNPWGEESYSDIIAKALESAP
FT                   DGRLKLNEIYQWFSDNIPYFGERSSPEEA (in isoform a)"
FT                   /evidence="ECO:0000303|PubMed:9353126"
FT                   /id="VSP_053106"
FT   VAR_SEQ         1..113
FT                   /note="MQLEQKSSLHCSKCRNFLQKFSQDMQAWNCRELDSPLPSDITLHNLEPARPD
FT                   SGMSFSTDFDDDFFNLDLHQQERSASFGGVTQYSQQFLREKCSFSPYFHTSLETVDSGR
FT                   TS -> MMEMLVDQGTDASSSASTSTSSVSRFGADTFMNTPDDVMMNDDMEPIPRDRCN
FT                   TWPMRRPQLEPPLNSSPIIHEQIPEEDAD (in isoform b and isoform c)"
FT                   /evidence="ECO:0000303|PubMed:9353126,
FT                   ECO:0000303|PubMed:9360933"
FT                   /id="VSP_053107"
FT   VAR_SEQ         1..54
FT                   /note="Missing (in isoform d)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053108"
FT   VAR_SEQ         1..24
FT                   /note="Missing (in isoform f)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042148"
FT   VAR_SEQ         152..154
FT                   /note="DFR -> E (in isoform b)"
FT                   /evidence="ECO:0000303|PubMed:9353126"
FT                   /id="VSP_053109"
FT   MUTAGEN         266
FT                   /note="R->K: Decreases methylation by prmt-1; when
FT                   associated with K-268 and K-270."
FT                   /evidence="ECO:0000269|PubMed:21531333"
FT   MUTAGEN         268
FT                   /note="R->K: Decreases methylation by prmt-1; when
FT                   associated with K-266 and K-270. Prevents phosphorylation
FT                   by akt 1 and/or 2; when associated with K-270."
FT                   /evidence="ECO:0000269|PubMed:21531333"
FT   MUTAGEN         270
FT                   /note="R->K: Decreases methylation by prmt-1; when
FT                   associated with K-266 and K-268. Prevents phosphorylation
FT                   by akt 1 and/or 2; when associated with K-268."
FT                   /evidence="ECO:0000269|PubMed:21531333"
FT   MUTAGEN         271
FT                   /note="S->A: Prevents phosphorylation and results in strong
FT                   nuclear localization. Reduces phosphorylation; when
FT                   associated with A-273."
FT                   /evidence="ECO:0000269|PubMed:11381260,
FT                   ECO:0000269|PubMed:21531333"
FT   MUTAGEN         273
FT                   /note="T->A: Prevents phosphorylation and results in strong
FT                   nuclear localization. Reduces phosphorylation in normal and
FT                   starved conditions. Reduces phosphorylation; when
FT                   associated with A-271."
FT                   /evidence="ECO:0000269|PubMed:11381260,
FT                   ECO:0000269|PubMed:21531333"
FT   MUTAGEN         319
FT                   /note="S->A: Prevents phosphorylation and results in
FT                   cytoplasmic localization in unc-43 n498 gain-of-function or
FT                   tax-6 mutant backgrounds."
FT                   /evidence="ECO:0000269|PubMed:23805378"
FT   MUTAGEN         319
FT                   /note="S->D: Phosphomimetic mutant which causes
FT                   constitutive nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:23805378"
FT   MUTAGEN         345
FT                   /note="S->A: Prevents phosphorylation and results in strong
FT                   nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:11381260"
FT   MUTAGEN         373..541
FT                   /note="Missing: In m27; defective dauer phase entry, but
FT                   animals are capable of entering a partial dauer state with
FT                   some dauer morphological characteristics. Reduces dex-1
FT                   expression in seam cells during the dauer phase."
FT                   /evidence="ECO:0000269|PubMed:30409788"
SQ   SEQUENCE   541 AA;  59732 MW;  8A36A86311A32CBB CRC64;
     MQLEQKSSLH CSKCRNFLQK FSQDMQAWNC RELDSPLPSD ITLHNLEPAR PDSGMSFSTD
     FDDDFFNLDL HQQERSASFG GVTQYSQQFL REKCSFSPYF HTSLETVDSG RTSLYGSNEQ
     CGQLGGASSN GSTAMLHTPD GSNSHQTSFP SDFRMSESPD DTVSGKKTTT RRNAWGNMSY
     AELITTAIMA SPEKRLTLAQ VYEWMVQNVP YFRDKGDSNS SAGWKNSIRH NLSLHSRFMR
     IQNEGAGKSS WWVINPDAKP GRNPRRTRER SNTIETTTKA QLEKSRRGAK KRIKERALMG
     SLHSTLNGNS IAGSIQTISH DLYDDDSMQG AFDNVPSSFR PRTQSNLSIP GSSSRVSPAI
     GSDIYDDLEF PSWVGESVPA IPSDIVDRTD QMRIDATTHI GGVQIKQESK PIKTEPIAPP
     PSYHELNSVR GSCAQNPLLR NPIVPSTNFK PMPLPGAYGN YQNGGITPIN WLSTSNSSPL
     PGIQSCGIVA AQHTVASSSA LPIDLENLTL PDQPLMDTMD VDALIRHELS QAGGQHIHFD
     L
//
